---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-007400"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2022-05-04T23:59:59+00:00"
generated_at: "2026-06-26T00:36:39.748093+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q1 revenue $30.6M (+33% YoY); narrows FY2022 guidance to $144M-$150M

## Summary
- Revenue $30.6M (+33.3% YoY); product revenue $25.7M (+40.9%).
- GAAP gross margin 14.5% vs 1.3% YoY; non-GAAP gross margin 14.8%.
- GAAP net loss ($36.9M) or ($0.78)/share; non-GAAP net loss ($31.9M) or ($0.67)/share.
- FY2022 revenue guidance narrowed to $144M-$150M (prior $142M-$150M), 40-46% growth.
- Appointed Dale E. Jones to Board; cash $335.6M; record Tablo Home console shipments.

## SEC filing metadata
- accession: 0000950170-22-007400
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2022-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017022007400/0000950170-22-007400-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017022007400/om-20220504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-007400
- JSON: https://secwatch.observer/filing/0000950170-22-007400.json
- Plain text: https://secwatch.observer/filing/0000950170-22-007400.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.